Professional Diagnostics Market Report by Product Type (Immunochemistry, Clinical Microbiology, Point of Care Test (POCT), Hematology, Hemostasis), End User ( Hospitals,  Diagnostic Laboratories, and Others), and Region 2024-2032

Professional Diagnostics Market Report by Product Type (Immunochemistry, Clinical Microbiology, Point of Care Test (POCT), Hematology, Hemostasis), End User ( Hospitals, Diagnostic Laboratories, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A8405
Buy Now

Market Overview:

The global professional diagnostics market size reached US$ 52.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 73.0 Billion by 2032, exhibiting a growth rate (CAGR) of 3.65% during 2024-2032. The increasing emphasis on early disease detection and preventive healthcare, continual advancements in data management and connectivity, and the growing prevalence of chronic diseases among the masses are some of the major factors propelling the market.

Report Attribute
 Key Statistics
Base Year
Forecast Years
Historical Years
Market Size in 2023 US$ 52.9 Billion
Market Forecast in 2032 US$ 73.0 Billion
Market Growth Rate 2024-2032

Professional diagnostics refer to specialized tools and expertise that are used to assess the health, condition, or performance of systems as well as living organisms. Typically conducted by trained professionals, they are characterized by their use of accurate, precise, and standardized procedures. They function by collecting data through specialized instruments, followed by analysis and interpretation of the data by professionals to make informed decisions. As a result, they contribute to providing objective measurements and aiding in disease detection, maintenance, quality control, research, and risk assessment in various fields. Professional diagnostics find extensive applications in healthcare, engineering, and automotive industries.

Professional Diagnostics Market

The market is majorly driven by the increasing prevalence of chronic diseases, including cardiovascular disorders, cancer, diabetes, and infectious diseases across the globe. In line with this, continual technological advancements in diagnostic technologies, such as molecular diagnostics, next-generation sequencing, and point-of-care testing, resulting in improved accuracy and efficiency of tests, are fueling the market growth. Moreover, considerable rise in the geriatric population leading to an increased demand for regular monitoring and diagnostic tests is also creating a positive market outlook. In addition to this, an enhanced focus on personalized medicine, non-invasive diagnostic tests, along with the expansion of point-of-care testing are also contributing to the growth of the market. Furthermore, the growing number of awareness and screening programs for early disease detection is resulting in a higher adoption on the global level.

Professional Diagnostics Market Trends/Drivers:

Increasing emphasis on early disease detection and preventive healthcare

As healthcare costs rise and patient outcomes improve, it is becoming increasingly important to detect and prevent diseases at an early stage. By identifying diseases at an early stage, professional diagnostics facilitate timely intervention and treatment for healthcare providers. Preventive measures are becoming increasingly important in healthcare, with screenings and diagnostic tests serving as important components. By aiding in the early detection of diseases and risk factors, these tests contribute to preventive healthcare and drive demand for professional diagnostics. Accurate and timely diagnosis of diseases is important for successful treatment. Early diagnosis also helps to reduce the mortality and morbidity associated with many diseases, as well as the costs associated with healthcare. This, in turn, is propelling the growth of the market.

Advancements in data management and connectivity

With the integration of diagnostic devices and advanced data management systems, the diagnostic process has been revolutionized. As a result of this integration, seamless data transfer, analysis, and interpretation become possible, enhancing the efficiency and accuracy of professional diagnostics. As a result of the streamlined flow of information, healthcare providers are able to make informed decisions and provide better care to patients. With enhanced data management and connectivity, diagnostic results can be quickly accessed, shared, and utilized, thereby leading to better diagnostic outcomes and contributing to the market growth. This leads to efficient and accurate treatments, leading to improved patient outcomes and satisfaction. Additionally, it also reduces the overall cost of healthcare services. This, in turn, leads to increased demand for diagnostic technologies, driving the market growth.

Rising adoption of companion diagnostics

The demand for companion diagnostics is growing as targeted therapies and personalized medicine advance. A companion diagnostic test is used to identify patients who will benefit from a particular therapeutic treatment. By identifying suitable candidates for these therapies based on patients' genetic or molecular profiles, professional diagnostics assist in selecting the right candidates for treatment. Professional diagnostics are in demand in clinical settings due to the adoption of companion diagnostics, which allows more precise and effective treatment approaches. This leads to better patient outcomes and improved patient safety. Clinical laboratories are increasingly looking for solutions that can accurately and quickly deliver companion diagnostic tests, which is driving the growth of the professional diagnostics market.

Professional Diagnostics Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global professional diagnostics market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product type and end user.

Breakup by Product Type:

Professional Diagnostics Market

  • Immunochemistry
  • Clinical Microbiology
  • Point of Care Test (POCT)
  • Hematology
  • Hemostasis

Point of Care Test (POCT) dominates the market

The report has provided a detailed breakup and analysis of the market based on the product type. This includes immunochemistry, clinical microbiology, point of care test (POCT), hematology, and hemostasis. According to the report, Point of Care Test (POCT) represented the largest segment.

Point-of-care testing (POCT) offers rapid and almost real-time results, eliminating the need for sample transportation and reducing the time taken for diagnosis and treatment decisions. It also enhances convenience and accessibility by allowing testing to be conducted with enhanced flexibility. This improves access to diagnostic services, especially in rural areas where healthcare facilities are typically limited.

Additionally, POCT provides results quicker than traditional lab testing since the tests are typically designed to be performed at the patient's bedside or in the doctor's office. This eliminates the need to transport samples and reduces wait time for results. As rapid results allow healthcare providers to make immediate clinical decisions, the adoption of professional diagnostics is expected to potentially save lives in emergency situations.

Breakup by End User:

  • Hospitals
  • Diagnostic Laboratories
  • Others

Hospitals hold a larger share in the market

A detailed breakup and analysis of the market based on the end use has also been provided in the report. This includes hospitals, diagnostic laboratories, and others. According to the report, hospitals accounted for the largest market share.

The main factors that are driving the growth of this segment are the increasing global geriatric population and the high incidence of chronic diseases. This results in greater patient numbers in hospitals, leading to a considerable rise in the need for diagnostic tests.

Hospitals rely on a diverse array of diagnostic tests to screen for diseases, make diagnoses, monitor patients, and make treatment decisions. These tests are crucial in determining the appropriate course of action for patients across various medical conditions. As a result, the demand for diagnostic tests is continually augmenting across hospitals to provide quality healthcare to their patients.

Breakup by Region:

Professional Diagnostics Market

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest professional diagnostics market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. 

North America held the biggest market share since the region has a well-developed medical infrastructure and comprises developed nations such as the United States and Canada. With state-of-the-art hospitals and medical facilities, North America is well-equipped to provide high-quality healthcare services.

Another factor contributing to the market in North America is the growing geriatric population requiring specialized healthcare services. Also, the geriatric population is more prone to developing chronic diseases and requires regular medical attention, leading to higher healthcare expenditure.

Additionally, the prevalence of chronic diseases in North America, such as diabetes, heart disease, and cancer requiring frequent monitoring and accurate diagnosis, is necessitating the use of advanced diagnostic tools and technologies. This, in turn, is creating lucrative opportunities in the market in North America.

Competitive Landscape:

The top players in the market are driving the market growth through strategic initiatives. These include extensive research and development efforts, expanding product portfolios, forming partnerships and collaborations, entering new geographic markets, pursuing mergers and acquisitions, emphasizing point-of-care testing, leveraging digital technologies, adopting a customer-centric approach, ensuring regulatory compliance and quality assurance, and investing in marketing and branding activities. These strategies enable them to stay at the forefront of innovation, meet diverse customer needs, expand their reach, enhance connectivity and efficiency, maintain high-quality standards, and establish strong market presence. Through these efforts, they aim to fuel the growth of the market and sustain their competitive edge.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • A. Menarini Diagnostics s.r.l
  • Abaxis, Inc. (Zoetis Inc.)
  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche AG
  • SEKISUI Diagnostics (Sekisui Medical Co. Ltd.)
  • Siemens AG
  • Thermo Fisher Scientific Inc.

Recent Developments:

  • In May 2023, A.Menarini Diagnostics S.r.l. introduced the PRIME MDx platform, a comprehensive molecular diagnostics platform that automates the entire process from sample handling to test results using real-time PCR technology. This platform enables the processing of diverse testing portfolios efficiently and seamlessly.
  • In July 2018, Abaxis Inc. was acquired by Zoetis Inc., a leader in the diagnostic services of animal health, for US $83 per share in cash, or approximately $2.0 billion in aggregate. This strategic move strengthened Zoetis' position as a leading provider of veterinary diagnostic solutions.
  • Thermo Fisher Scientific announced in 2023 that it is partnering with AstraZeneca to develop a solid tissue and blood-based companion diagnostic (CDx) test for Osimertinib. The CDx is expected to identify patients with non-small cell lung cancer who may be eligible for treatment with Osimertinib by identifying tumors which exhibit epidermal growth factor receptor (EGFR) alterations.

Professional Diagnostics Market Report Scope:

Report Features Details
Base Year of the Analysis 2023
 Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Scope of the Report Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment: 
  • Product Type
  • End User
  • Region
Product Types Covered Immunochemistry, Clinical Microbiology, Point of Care Test (POCT), Hematology, Hemostasis
End Users Covered Hospitals, Diagnostic Laboratories, Others
Regions Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered A. Menarini Diagnostics s.r.l, Abaxis, Inc. (Zoetis Inc.), Abbott Laboratories, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, SEKISUI Diagnostics (Sekisui Medical Co. Ltd.), Siemens AG, Thermo Fisher Scientific Inc., etc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report:

  • How has the global professional diagnostics market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global professional diagnostics market?
  • What is the impact of each driver, restraint, and opportunity on the global professional diagnostics market?
  • What are the key regional markets?
  • Which countries represent the most attractive professional diagnostics market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the professional diagnostics market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the professional diagnostics market?
  • What is the competitive structure of the global professional diagnostics market?
  • Who are the key players/companies in the global professional diagnostics market?

Key Benefits for Stakeholders:

  • IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the professional diagnostics market from 2018-2032.
  • The research study provides the latest information on the market drivers, challenges, and opportunities in the global professional diagnostics market.
  • The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the professional diagnostics industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Professional Diagnostics Market Report by Product Type (Immunochemistry, Clinical Microbiology, Point of Care Test (POCT), Hematology, Hemostasis), End User ( Hospitals,  Diagnostic Laboratories, and Others), and Region 2024-2032
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More